Raymond K. Walters
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Raymond K. Walters.
Biological Psychiatry | 2012
Gitta H. Lubke; Jouke-Jan Hottenga; Raymond K. Walters; Charles Laurin; Eco J. C. de Geus; G. Willemsen; Jan Smit; Christel M. Middeldorp; Brenda W.J.H. Penninx; Jacqueline M. Vink; Dorret I. Boomsma
Genome-wide association studies of psychiatric disorders have been criticized for their lack of explaining a considerable proportion of the heritability established in twin and family studies. Genome-wide association studies of major depressive disorder in particular have so far been unsuccessful in detecting genome-wide significant single nucleotide polymorphisms (SNPs). Using two recently proposed methods designed to estimate the heritability of a phenotype that is attributable to genome-wide SNPs, we show that SNPs on current platforms contain substantial information concerning the additive genetic variance of major depressive disorder. To assess the consistency of these two methods, we analyzed four other complex phenotypes from different domains. The pattern of results is consistent with estimates of heritability obtained in twin studies carried out in the same population.
American Journal of Human Genetics | 2017
Alicia R. Martin; Christopher R. Gignoux; Raymond K. Walters; Genevieve L Wojcik; Benjamin M. Neale; Simon Gravel; Mark J. Daly; Carlos Bustamante; Eimear E. Kenny
The vast majority of genome-wide association studies (GWASs) are performed in Europeans, and their transferability to other populations is dependent on many factors (e.g., linkage disequilibrium, allele frequencies, genetic architecture). As medical genomics studies become increasingly large and diverse, gaining insights into population history and consequently the transferability of disease risk measurement is critical. Here, we disentangle recent population history in the widely used 1000 Genomes Project reference panel, with an emphasis on populations underrepresented in medical studies. To examine the transferability of single-ancestry GWASs, we used published summary statistics to calculate polygenic risk scores for eight well-studied phenotypes. We identify directional inconsistencies in all scores; for example, height is predicted to decrease with genetic distance from Europeans, despite robust anthropological evidence that West Africans are as tall as Europeans on average. To gain deeper quantitative insights into GWAS transferability, we developed a complex trait coalescent-based simulation framework considering effects of polygenicity, causal allele frequency divergence, and heritability. As expected, correlations between true and inferred risk are typically highest in the population from which summary statistics were derived. We demonstrate that scores inferred from European GWASs are biased by genetic drift in other populations even when choosing the same causal variants and that biases in any direction are possible and unpredictable. This work cautions that summarizing findings from large-scale GWASs may have limited portability to other populations using standard approaches and highlights the need for generalized risk prediction methods and the inclusion of more diverse individuals in medical genomics.
Nature Genetics | 2017
Daniel J. Weiner; Emilie M. Wigdor; Stephan Ripke; Raymond K. Walters; Jack A. Kosmicki; Jakob Grove; Kaitlin E. Samocha; Jacqueline I. Goldstein; Aysu Okbay; Jonas Bybjerg-Grauholm; Thomas Werge; David M. Hougaard; Jacob M. Taylor; David Skuse; Bernie Devlin; Richard Anney; Stephan J. Sanders; Somer L. Bishop; Preben Bo Mortensen; Anders D. Børglum; George Davey Smith; Mark J. Daly; Elise B. Robinson
Autism spectrum disorder (ASD) risk is influenced by common polygenic and de novo variation. We aimed to clarify the influence of polygenic risk for ASD and to identify subgroups of ASD cases, including those with strongly acting de novo variants, in which polygenic risk is relevant. Using a novel approach called the polygenic transmission disequilibrium test and data from 6,454 families with a child with ASD, we show that polygenic risk for ASD, schizophrenia, and greater educational attainment is over-transmitted to children with ASD. These findings hold independent of proband IQ. We find that polygenic variation contributes additively to risk in ASD cases who carry a strongly acting de novo variant. Lastly, we show that elements of polygenic risk are independent and differ in their relationship with phenotype. These results confirm that the genetic influences on ASD are additive and suggest that they create risk through at least partially distinct etiologic pathways.
bioRxiv | 2017
Ditte Demontis; Raymond K. Walters; Joanna Martin; Manuel Mattheisen; Thomas Damm Als; Esben Agerbo; Rich Belliveau; Jonas Bybjerg-Grauholm; Marie Bækved-Hansen; Felecia Cerrato; Claire Churchhouse; Ashley Dumont; Nicholas Eriksson; Michael J. Gandal; Jacqueline I. Goldstein; Jakob Grove; Christine Søholm Hansen; Mads Engel Hauberg; Mads V. Hollegaard; Daniel P. Howrigan; Hailiang Huang; Julian Maller; Jennifer L. Moran; Jonatan Pallesen; Duncan S. Palmer; Carsten Bøcker Pedersen; Timothy Poterba; Jesper Buchhave Poulsen; Stephan Ripke; Elise B. Robinson
Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of school-age children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no individual variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 ADHD cases and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, revealing new and important information on the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes, as well as around brain-expressed regulatory marks. These findings, based on clinical interviews and/or medical records are supported by additional analyses of a self-reported ADHD sample and a study of quantitative measures of ADHD symptoms in the population. Meta-analyzing these data with our primary scan yielded a total of 16 genome-wide significant loci. The results support the hypothesis that clinical diagnosis of ADHD is an extreme expression of one or more continuous heritable traits.
American Journal of Psychiatry | 2017
Laramie Duncan; Zeynep Yilmaz; Héléna A. Gaspar; Raymond K. Walters; Jackie Goldstein; Verneri Anttila; Brendan Bulik-Sullivan; Stephan Ripke; Laura M. Thornton; Anke Hinney; Mark J. Daly; Patrick F. Sullivan; Eleftheria Zeggini; Gerome Breen; Cynthia M. Bulik
OBJECTIVE The authors conducted a genome-wide association study of anorexia nervosa and calculated genetic correlations with a series of psychiatric, educational, and metabolic phenotypes. METHOD Following uniform quality control and imputation procedures using the 1000 Genomes Project (phase 3) in 12 case-control cohorts comprising 3,495 anorexia nervosa cases and 10,982 controls, the authors performed standard association analysis followed by a meta-analysis across cohorts. Linkage disequilibrium score regression was used to calculate genome-wide common variant heritability (single-nucleotide polymorphism [SNP]-based heritability [h2SNP]), partitioned heritability, and genetic correlations (rg) between anorexia nervosa and 159 other phenotypes. RESULTS Results were obtained for 10,641,224 SNPs and insertion-deletion variants with minor allele frequencies >1% and imputation quality scores >0.6. The h2SNP of anorexia nervosa was 0.20 (SE=0.02), suggesting that a substantial fraction of the twin-based heritability arises from common genetic variation. The authors identified one genome-wide significant locus on chromosome 12 (rs4622308) in a region harboring a previously reported type 1 diabetes and autoimmune disorder locus. Significant positive genetic correlations were observed between anorexia nervosa and schizophrenia, neuroticism, educational attainment, and high-density lipoprotein cholesterol, and significant negative genetic correlations were observed between anorexia nervosa and body mass index, insulin, glucose, and lipid phenotypes. CONCLUSIONS Anorexia nervosa is a complex heritable phenotype for which this study has uncovered the first genome-wide significant locus. Anorexia nervosa also has large and significant genetic correlations with both psychiatric phenotypes and metabolic traits. The study results encourage a reconceptualization of this frequently lethal disorder as one with both psychiatric and metabolic etiology.
Translational Psychiatry | 2016
S Stringer; Camelia C. Minică; Karin J. H. Verweij; Hamdi Mbarek; Manon Bernard; Jaime Derringer; K.R. van Eijk; Joshua D. Isen; Anu Loukola; D.F. Maciejewski; Evelin Mihailov; P.J. van der Most; Cristina Sánchez-Mora; Leonie Roos; Richard Sherva; Raymond K. Walters; Jennifer J. Ware; Abdel Abdellaoui; Timothy B. Bigdeli; Susan J. T. Branje; Sandra A. Brown; Marcel Bruinenberg; Miguel Casas; Tonu Esko; Iris Garcia-Martínez; S. D. Gordon; Juliette Harris; Catharina A. Hartman; Anjali K. Henders; A. C. Heath
Cannabis is the most widely produced and consumed illicit psychoactive substance worldwide. Occasional cannabis use can progress to frequent use, abuse and dependence with all known adverse physical, psychological and social consequences. Individual differences in cannabis initiation are heritable (40–48%). The International Cannabis Consortium was established with the aim to identify genetic risk variants of cannabis use. We conducted a meta-analysis of genome-wide association data of 13 cohorts (N=32 330) and four replication samples (N=5627). In addition, we performed a gene-based test of association, estimated single-nucleotide polymorphism (SNP)-based heritability and explored the genetic correlation between lifetime cannabis use and cigarette use using LD score regression. No individual SNPs reached genome-wide significance. Nonetheless, gene-based tests identified four genes significantly associated with lifetime cannabis use: NCAM1, CADM2, SCOC and KCNT2. Previous studies reported associations of NCAM1 with cigarette smoking and other substance use, and those of CADM2 with body mass index, processing speed and autism disorders, which are phenotypes previously reported to be associated with cannabis use. Furthermore, we showed that, combined across the genome, all common SNPs explained 13–20% (P<0.001) of the liability of lifetime cannabis use. Finally, there was a strong genetic correlation (rg=0.83; P=1.85 × 10−8) between lifetime cannabis use and lifetime cigarette smoking implying that the SNP effect sizes of the two traits are highly correlated. This is the largest meta-analysis of cannabis GWA studies to date, revealing important new insights into the genetic pathways of lifetime cannabis use. Future functional studies should explore the impact of the identified genes on the biological mechanisms of cannabis use.
Journal of the American Academy of Child and Adolescent Psychiatry | 2014
Kelly S. Benke; Michel G. Nivard; Fleur P. Velders; Raymond K. Walters; Irene Pappa; Paul Scheet; Xiangjun Xiao; Erik A. Ehli; Lyle J. Palmer; Andrew J. O. Whitehouse; Frank C. Verhulst; Vincent W. V. Jaddoe; Fernando Rivadeneira; Maria M. Groen-Blokhuis; Catharina E. M. van Beijsterveldt; Gareth E. Davies; James J. Hudziak; Gitta H. Lubke; Dorret I. Boomsma; Craig E. Pennell; Henning Tiemeier; Christel M. Middeldorp
OBJECTIVE Preschool internalizing problems (INT) are highly heritable and moderately genetically stable from childhood into adulthood. Gene-finding studies are scarce. In this study, the influence of genome-wide measured single nucleotide polymorphisms (SNPs) was investigated in 3 cohorts (total N = 4,596 children) in which INT was assessed with the same instrument, the Child Behavior Checklist (CBCL). METHOD First, genome-wide association (GWA) results were used for density estimation and genome-wide complex trait analysis (GCTA) to calculate the variance explained by all SNPs. Next, a fixed-effect inverse variance meta-analysis of the 3 GWA analyses was carried out. Finally, the overlap in results with prior GWA studies of childhood and adulthood psychiatric disorders and treatment responses was tested by examining whether SNPs associated with these traits jointly showed a significant signal for INT. RESULTS Genome-wide SNPs explained 13% to 43% of the total variance. This indicates that the genetic architecture of INT mirrors the polygenic model underlying adult psychiatric traits. The meta-analysis did not yield a genome-wide significant signal but was suggestive for the PCSK2 gene located on chromosome 20p12.1. SNPs associated with other psychiatric disorders appeared to be enriched for signals with INT (λ = 1.26, p < .03). CONCLUSION Our study provides evidence that INT is influenced by many common genetic variants, each with a very small effect, and that, even as early as age 3, genetic variants influencing INT overlap with variants that play a role in childhood and adulthood psychiatric disorders.
Nature Genetics | 2018
Patrick Turley; Raymond K. Walters; Omeed Maghzian; Aysu Okbay; James J. Lee; Mark Alan Fontana; Tuan Anh Nguyen-Viet; Robbee Wedow; Meghan Zacher; Nicholas A. Furlotte; Patrik K. E. Magnusson; Sven Oskarsson; Magnus Johannesson; Peter M. Visscher; David Laibson; David Cesarini; Benjamin M. Neale; Daniel J. Benjamin
We introduce multi-trait analysis of GWAS (MTAG), a method for joint analysis of summary statistics from genome-wide association studies (GWAS) of different traits, possibly from overlapping samples. We apply MTAG to summary statistics for depressive symptoms (Neff = 354,862), neuroticism (N = 168,105), and subjective well-being (N = 388,538). As compared to the 32, 9, and 13 genome-wide significant loci identified in the single-trait GWAS (most of which are themselves novel), MTAG increases the number of associated loci to 64, 37, and 49, respectively. Moreover, association statistics from MTAG yield more informative bioinformatics analyses and increase the variance explained by polygenic scores by approximately 25%, matching theoretical expectations.MTAG is a new method for joint analysis of summary statistics from genome-wide association studies of different traits. Applying MTAG to summary statistics for depressive symptoms, neuroticism and subjective well-being increased discovery of associated loci as compared to single-trait analyses.
Nature Genetics | 2018
James J. Lee; Robbee Wedow; Aysu Okbay; Edward Kong; Omeed Maghzian; Meghan Zacher; Tuan Anh Nguyen-Viet; Peter Bowers; Julia Sidorenko; Richard Karlsson Linner; Mark Alan Fontana; Tushar Kundu; Chanwook Lee; Hui Li; Ruoxi Li; Rebecca Royer; Pascal Timshel; Raymond K. Walters; Emily Willoughby; Loic Yengo; Maris Alver; Yanchun Bao; David W. Clark; Felix R. Day; Nicholas A. Furlotte; Peter K. Joshi; Kathryn E. Kemper; Aaron Kleinman; Claudia Langenberg; Reedik Mägi
Here we conducted a large-scale genetic association analysis of educational attainment in a sample of approximately 1.1 million individuals and identify 1,271 independent genome-wide-significant SNPs. For the SNPs taken together, we found evidence of heterogeneous effects across environments. The SNPs implicate genes involved in brain-development processes and neuron-to-neuron communication. In a separate analysis of the X chromosome, we identify 10 independent genome-wide-significant SNPs and estimate a SNP heritability of around 0.3% in both men and women, consistent with partial dosage compensation. A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11–13% of the variance in educational attainment and 7–10% of the variance in cognitive performance. This prediction accuracy substantially increases the utility of polygenic scores as tools in research.Gene discovery and polygenic predictions from a genome-wide association study of educational attainment in 1.1 million individuals.
Bioinformatics | 2012
Raymond K. Walters; Charles Laurin; Gitta H. Lubke
MOTIVATION There is growing momentum to develop statistical learning (SL) methods as an alternative to conventional genome-wide association studies (GWAS). Methods such as random forests (RF) and gradient boosting machine (GBM) result in variable importance measures that indicate how well each single-nucleotide polymorphism (SNP) predicts the phenotype. For RF, it has been shown that variable importance measures are systematically affected by minor allele frequency (MAF) and linkage disequilibrium (LD). To establish RF and GBM as viable alternatives for analyzing genome-wide data, it is necessary to address this potential bias and show that SL methods do not significantly under-perform conventional GWAS methods. RESULTS Both LD and MAF have a significant impact on the variable importance measures commonly used in RF and GBM. Dividing SNPs into overlapping subsets with approximate linkage equilibrium and applying SL methods to each subset successfully reduces the impact of LD. A welcome side effect of this approach is a dramatic reduction in parallel computing time, increasing the feasibility of applying SL methods to large datasets. The created subsets also facilitate a potential correction for the effect of MAF using pseudocovariates. Simulations using simulated SNPs embedded in empirical data-assessing varying effect sizes, minor allele frequencies and LD patterns-suggest that the sensitivity to detect effects is often improved by subsetting and does not significantly under-perform the Armitage trend test, even under ideal conditions for the trend test. AVAILABILITY Code for the LD subsetting algorithm and pseudocovariate correction is available at http://www.nd.edu/~glubke/code.html.